Correlation Between Alliance Data and Viridian Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alliance Data and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alliance Data and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alliance Data Systems and Viridian Therapeutics, you can compare the effects of market volatilities on Alliance Data and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alliance Data with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alliance Data and Viridian Therapeutics.

Diversification Opportunities for Alliance Data and Viridian Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Alliance and Viridian is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Alliance Data Systems and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Alliance Data is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alliance Data Systems are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Alliance Data i.e., Alliance Data and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between Alliance Data and Viridian Therapeutics

Assuming the 90 days trading horizon Alliance Data Systems is expected to generate 0.57 times more return on investment than Viridian Therapeutics. However, Alliance Data Systems is 1.75 times less risky than Viridian Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  4,850  in Alliance Data Systems on October 8, 2024 and sell it today you would earn a total of  1,404  from holding Alliance Data Systems or generate 28.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Alliance Data Systems  vs.  Viridian Therapeutics

 Performance 
       Timeline  
Alliance Data Systems 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Alliance Data Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Alliance Data unveiled solid returns over the last few months and may actually be approaching a breakup point.
Viridian Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Alliance Data and Viridian Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alliance Data and Viridian Therapeutics

The main advantage of trading using opposite Alliance Data and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alliance Data position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.
The idea behind Alliance Data Systems and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated